Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Biocartis prices EUR 100M IPO

    Molecular diagnostics company Biocartis Group N.V. (Euronext:BCART) raised EUR 100 million ($107.8 million) through the sale of 8.7 million shares at EUR 11.50 in an IPO on Euronext Brussels. Underwriters were KBC …

    Published on 4/24/2015
  • FINANCIAL NEWS: Pfenex raises $40.5 million in follow-on

    Pfenex Inc. (NYSE-M:PFNX) raised $40.5 million through the sale of 2.6 million shares at $15.50 in a follow-on underwritten by Barclays; Evercore; and William Blair. Existing stockholders also sold 3.4 million shares in…

    Published on 4/24/2015
  • FINANCIAL NEWS: Jounce raises $56M in series B round

    Cancer company Jounce Therapeutics Inc. (Cambridge, Mass.) raised $56 million in a series B round from Wellington Management, Redmile Group, Nextech Invest, Pharmstandard International, Cormorant Asset Management, Omega…

    Published on 4/23/2015
  • FINANCIAL NEWS: WuXi NextCODE invests $15M in DNAnexus

    The WuXi NextCODE Genomics subsidiary of WuXi PharmaTech Inc. (NYSE:WX) partnered with DNAnexus Inc. (Mountain View, Calif.) and invested $15 million in the genome informatics company. The companies intend to create new…

    Published on 4/23/2015
  • FINANCIAL NEWS: Oberland tops target with $425M royalty and credit fund

    Oberland Capital raised its first fund, a $425 million healthcare royalty and credit opportunities investment vehicle. The firm, which exceeded its $350 million target, plans to invest the Oberland Capital Healthcare …

    Published on 4/22/2015
  • FINANCIAL NEWS: SciFluor raises $30M in series A

    Allied Minds plc (LSE:ALM) subsidiary SciFluor Life Sciences LLC (Cambridge, Mass.) raised $30 million in an untranched series A round led by new investors Invesco Asset Management and Woodford Investment Management. …

    Published on 4/22/2015
  • FINANCIAL NEWS: Dimension raises $65M in series B

    Dimension Therapeutics Inc. (Cambridge, Mass.) raised $65 million in a series B round led by new investor New Leaf Venture Partners. Other new investors included Jennison Associates; Partner Fund Management; RA Capital;…

    Published on 4/21/2015
  • FINANCIAL NEWS: Brandon Capital closes A$200M life science fund

    Brandon Capital raised A$200 million ($156.3 million) for its Medical Research Commercialisation Fund (MRCF3), which the firm said is Australia's largest life science venture fund to date. Existing investors …

    Published on 4/20/2015
  • FINANCIAL NEWS: Woodford closes L800M oversubscribed fund

    Woodford Investment Management LLP raised L800 million ($1.2 billion) for its Woodford Patient Capital Trust plc fund ahead of its listing on LSE. The fund, expected to trade on LSE beginning Tuesday, was oversubscribed…

    Published on 4/20/2015
  • FINANCIAL NEWS: Atlas closes $280M life sciences-only fund

    Atlas Venture closed its oversubscribed $280 million Atlas Fund X, the firm's first fund since becoming an exclusively life sciences-focused VC.Formerly a hybrid firm, Atlas separated its tech and life sciences teams …

    Published on 4/17/2015
  • FINANCIAL NEWS: Follow-on roundup: Horizon, Akebia

    Horizon Pharma plc (NASDAQ:HZNP) raised $433.6 million through the sale of 15.4 million shares at $28.25 in a follow-on underwritten by Citigroup; Jefferies; Cowen; and Morgan Stanley. Horizon proposed the offering …

    Published on 4/17/2015
  • FINANCIAL NEWS: KemPharm raises $56 million in IPO

    KemPharm Inc. (NASDAQ: KMPH) gained $0.20 to $11.20 in its first day of trading after it raised $56 million in an IPO through the sale of 5.1 million shares at $11. The IPO price values KemPharm at $148.1 million. Cowen…

    Published on 4/16/2015
  • FINANCIAL NEWS: Cidara raises $76.8M in bumped-up IPO

    Anti-infective play Cidara Therapeutics Inc. (NASDAQ:CDTX) was unchanged at $16 in its first day of trading on Wednesday after raising $76.8 million in an IPO through the sale of 4.8 million shares at $16. The offering …

    Published on 4/15/2015
  • FINANCIAL NEWS: Follow-on roundup: Sage, Foamix

    Sage Therapeutics Inc. (NASDAQ:SAGE) and Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) raised a combined $180 million in follow-on offerings on Wednesday. Sage raised $120 million through the sale of 2.3 million shares at $…

    Published on 4/15/2015
  • FINANCIAL NEWS: NEA raises $3.2B for two funds

    New Enterprise Associates raised a total of $3.2 billion for two funds, including $2.8 billion for NEA 15 and $350 million for an adjunct fund, NEA 15 Opportunity Fund. The firm had targeted $2.5 billion for NEA 15 (see…

    Published on 4/15/2015
  • FINANCIAL NEWS: XBiotech raises $76M in IPO

    XBiotech Inc. (NASDAQ:XBIT) gained $4.25 (22%) to $23.25 in its first day of trading Wednesday after raising $76 million in an IPO through the sale of 4 million shares at $19. The price, which was the middle of the …

    Published on 4/15/2015
  • FINANCIAL NEWS: Merus Labs raises C$60M in bought deal

    Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI) raised C$60 million (US$47.5 million) on Monday through the sale of 19.7 million shares at C$3.05 to underwriters in a bought deal. Clarus Securities; Cormark …

    Published on 4/14/2015
  • FINANCIAL NEWS: Venture tracks

    Venture firm Truffle Capital promoted Antoine Pau to partner. Pau had been an investment director.

    Published on 4/14/2015
  • FINANCIAL NEWS: TVM raises $50M toward China fund

    TVM Capital Life Science announced a first close of $50 million for its China BioPharma Capital I fund, which the firm plans to invest in Western companies that intend to obtain licenses to develop and commercialize …

    Published on 4/13/2015
  • FINANCIAL NEWS: Venture tracks

    MPM Capital hired Gregory Sieczkiewicz as managing director and chief counsel for intellectual property. Sieczkiewicz was VP of intellectual property at Flagship Ventures.

    Published on 4/13/2015
  • FINANCIAL NEWS: Voyager raises $60M in series B

    Voyager Therapeutics Inc. (Cambridge, Mass.) raised $60 million in an untranched series B round led by new investors Brookside Capital and Partner Fund Management. Wellington Management; Casdin Capital; and two …

    Published on 4/13/2015
  • FINANCIAL NEWS: uniQure raises $88.5M in follow-on

    Gene therapy company uniQure N.V. (NASDAQ:QURE) raised $88.5 million through the sale of 3 million shares at $29.50 in a follow-on underwritten by Leerink; Cowen; Piper Jaffray; Oppenheimer; and H.C. Wainwright. uniQure…

    Published on 4/10/2015
  • FINANCIAL NEWS: Edge raises $72.5M in additional series C rounds

    Neurology company Edge Therapeutics Inc. (Berkeley Heights, N.J.) raised a combined $72.5 million in series C-1 and C-2 rounds. Edge raised $56 million this month in a C-2 round led by Venrock. Sofinnova Ventures; …

    Published on 4/9/2015
  • FINANCIAL NEWS: Woodford raises fund ceiling to L800M

    Woodford Investment Management LLP raised the ceiling of its Woodford Patient Capital Trust plc fund to L800 million ($1.2 billion) from L500 million ($746.6 million), after exceeding its initial target of L200 million…

    Published on 4/9/2015
  • FINANCIAL NEWS: Alzheon raises $10M in series A round

    Alzheon Inc. (Framingham, Mass.) raised $10 million in a series A round led by new investor Ally Bridge Group. Undisclosed new and existing investors also participated. CEO Martin Tolar told BioCentury the company hopes…

    Published on 4/8/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993